Photo by atikahakhtar from unsplash
In summary, both apremilast monotherapy and combination therapy result in favorable 52-week maintenance of therapeutic response in approximately two thirds of patients, with minimal mild-to-moderate AEs during weeks 16-52 of… Click to show full abstract
In summary, both apremilast monotherapy and combination therapy result in favorable 52-week maintenance of therapeutic response in approximately two thirds of patients, with minimal mild-to-moderate AEs during weeks 16-52 of treatment. As such, physicians can consider using apremilast in combination with biologic or systemic agents for long-term maintenance of disease control in patients presenting with challenging psoriasis that cannot be controlled with 1 agent alone.
Keywords:
induced changes;
noted trichoscopy;
steroid induced;
patients frontal;
trichoscopy patients;
changes noted
Journal Title: Journal of the American Academy of Dermatology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American Academy of Dermatology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!